UAB Media Contact: Tyler Greer | email@example.com
September 23, 2015, Standard treatment better than proposed alternative for unexplained infertility Treatment with clomiphene, a standard therapy for couples with unexplained infertility, results in more live births than treatment with a potential alternative, letrozole, according to a landmark study of more than 900 couples conducted by a National Institutes of Health research network, which included the University of Alabama at Birmingham School of Medicine’s Division of Reproductive Endocrinology and Infertility. G. Wright Bates, M.D., professor of Reproductive Endocrinology in the Department of Obstetrics and Gynecology and principal investigator for the UAB site, one of 12 locations around the country.UAB Media Contact: Tyler Greer | firstname.lastname@example.org
UAB Medicine received a 2015 Women's Choice Award, having been named one of "America's Best Hospitals for Obstetrics". The honor was based on a review of services, patient satisfaction scores, and a strong record of clinical care and full-term deliveries.Women's Choice Award is a consumer advocacy group that helps women make smart health care decisions. This marks the third year that the group has presented the award to the nation's leading obstetrics programs. UAB Obstetrics has earned this recognition for each of those three years, in the category for hospitals with 400-plus beds. Read more in ONE . . .
The University of Alabama at Birmingham Department of Obstetrics and Gynecology and the Department of Biostatistics have been awarded a $19.31 million R01 grant by the National Institutes of Health’s Heart, Lung and Blood Institute to coordinate the most comprehensive study of chronic hypertension in pregnancy ever undertaken.The Chronic Hypertension and Pregnancy Project (CHAP) is a multicenter, randomized trial which will enroll between 4,700 and 5,700 pregnant women during the next six years with a primary aim to evaluate the benefits and potential harms of pharmacologic treatment of mild chronic hypertension in pregnancy. Alan Tita, M.D., Ph.D., Professor of Obstetrics and Gynecology in UAB’s School of Medicine is principal investigator/project director for CHAP. UAB Media Contact: Tyler Greer | email@example.com
UAB has enrolled the first U.S. patient in a Phase III clinical trial for a drug that, if successful, would be a significant clinical breakthrough for reducing pre-term births and infant mortality. Alan Tita, M.D., Ph.D., professor of Obstetrics and Gynecology is lead investigator for the trial.
The editorial team at Becker's Hospital Review included hospitals on its list based on the comprehensiveness of their women's health programs and the quality of care they offer. Hospitals included on the list have been recognized for women's health by several organizations, including U.S.News & World Report, Healthgrades, UNICEF's Baby-Friendly Hospital Initiative, and CareChex.UAB's Women & Infants Center covers the full spectrum of routine and complex obstetrics and gynecology services, including specialized urogynecology, infertility, gynecologic oncology, and minimally invasive and robotic surgery.UAB Hospital is the only hospital in central and north Alabama to participate in Best Fed Beginnings. Also, together with Children's Hospital of Alabama, UAB's Regional NICU is Alabama's only Level IV Unit, and the connecting sky bridge between the two entities provides a seamless transition for babies who require advanced inpatient care at both locations. UAB neonatologists are available in-house 24 hours a day, 365 days a year. Read more in ONE . . .
December 17, 2013, Faculty become Students to Learn Simulation Training -Health professionals across campus, including 14 from the School of Medicine and UAB Hospital, completed an extensive week-long course in medical simulation training — a first step toward building a world-class program at UAB. The Department of Ob/Gyn's faculty member, Chere' Stewart, MD, who is also the Associate Director for the Ob/Gyn Medical Student Clerkship, was a participate in this program. |Story by Cliniton Colmenares